Human Technopole

Human Technopole The next-generation life sciences institute advancing human health through basic research and collaboration.

Human Technopole’s mission is to improve human life and technology, and will be implemented through the achievement of four main objectives:

1) to foster fundamental cutting-edge research on human biology and human health;

2) to provide shared infrastructures to the national scientific community;

3) to offer advanced scientific training to scientists;

4) to enable the exploitation of research and technological innovation results via technology transfer.

28/04/2026

🦺 How can science thrive safely and responsibly?

🤝 For World Day for Safety and Health at Work , our Ivana Milone, Head of HSE, reflects on the role of safety in research.

🔬 At Human Technopole, this means working side by side with researchers: assessing risks, understanding new processes and finding safe ways to move forward together. Safety is part of how we shape the future of human health: by creating the conditions for innovation to grow responsibly, through continuous exchange and shared perspectives.

🧬 What does it take to understand life’s complexity?🔬 At Human Technopole, we connect research, technologies, training a...
23/04/2026

🧬 What does it take to understand life’s complexity?

🔬 At Human Technopole, we connect research, technologies, training and innovation to explore human biology across scales, from molecules to populations.

🚀 This is how we turn complexity into discovery, and discovery into new opportunities for human health. A shared mission, shaped by people, ideas and collaboration.

Watch the video 👉 https://youtu.be/okWehgenNMM

Discover more 👉 https://humantechnopole.it/en/news/human-technopole-connecting-science-across-scales/

Human Technopole: Connecting Science Across Scales

💡 What does it take to build a research institute that truly serves human health and sets a new standard for how science...
22/04/2026

💡 What does it take to build a research institute that truly serves human health and sets a new standard for how science is done?

🤝 Today at the Senato della Repubblica in Rome, Human Technopole gathered with institutions, members of the scientific community, and innovation partners to present the results of the past two years, discuss our model of open research in life sciences and why it matters for Italy and beyond.

🔍 The conversation covered the ground that defines us: the strategic value of basic research with no limits on discovery; the power of interdisciplinary collaboration and open infrastructure; the rigour and international standards that make a research model credible; and the connection between fundamental science and a broader innovation ecosystem. Taken together, these are not separate themes, they are one vision: shaping the future of human health, together.

🙏 A heartfelt thank you to Senator for Life Prof. Elena Cattaneo for creating this space for dialogue, to Vice President Licia Ronzulli, to the founding ministries (Ministero della Salute Ministero dell'Università e della Ricerca Ministero dell'Economia e delle Finanze), Cristina Rossello and to all our speakers: our President Gianmario Verona, our Director Marino Zerial, Filippo Mancia (Columbia University), Giuseppe Remuzzi (Istituto di Ricerche Farmacologiche Mario Negri IRCCS), Igor De Biasio (Principia SpA) and to the moderator Laura Chimenti (RAI).

Read more here: https://humantechnopole.it/en/news/human-technopole-scales-up-italian-science-for-europes-health-future/

🧠 What happens when bold ideas meet research, technology and collaboration? 📍From 11 to 16 May 2026, for MIND Milano Inn...
21/04/2026

🧠 What happens when bold ideas meet research, technology and collaboration?

📍From 11 to 16 May 2026, for MIND Milano Innovation District , Human Technopole hosts two events, contributing to a week dedicated to innovation and to the ideas shaping the future.

🤖 11 May – “AI Applications of Large Biomedical Data”, keynote lecture by Prof. Carlo Bifulco, Providence Healthcare System and Providence Cancer Institute. Register here 👉 https://humantechnopole.it/en/trainings/ai-applications-of-large-biomedical-data/

📊 13 May – “The Impact of AI on Health Data: From Research to Policy”, organised by the Centre for Innovation and Technology Transfer in collaboration with Federchimica Assobiotec. Register here 👉 https://humantechnopole.it/en/trainings/the-impact-of-ai-on-health-data/

🧩 How is one of the body’s giant receptors regulated? 🔬 Researchers in the Coscia Group at Human Technopole have uncover...
20/04/2026

🧩 How is one of the body’s giant receptors regulated?

🔬 Researchers in the Coscia Group at Human Technopole have uncovered how the chaperone LRPAP1 binds Megalin, a major receptor involved in cellular uptake across organs including the kidney, brain, eye and thyroid. Published in Communications Biology, the study reveals a more complex interaction than previously thought.

💡 By showing how LRPAP1 can regulate access to Megalin and displace thyroglobulin, this work deepens our understanding of receptor biology in health and disease, and opens new paths for studying related disorders.

Read more 👉

🤖 Can AI unlock more from standard pathology slides? 🔬 On 11 May, Human Technopole will host a keynote lecture by Prof. ...
17/04/2026

🤖 Can AI unlock more from standard pathology slides?

🔬 On 11 May, Human Technopole will host a keynote lecture by Prof. Carlo Bifulco of Providence health system on how AI is opening new paths in cancer research, from pathology foundation models and immune phenotypes to virtual staining and multimodal approaches for precision oncology.

🧬 Organised by the Centre for Innovation and Technology Transfer, the event is part of Week and brings together perspectives across pathology, data and clinical research.

Register by 26 April 👉 https://humantechnopole.it/en/trainings/ai-applications-of-large-biomedical-data/ MIND Milano Innovation District

🧬 How do B cells choose between fast defence and long-term protection? 🔬 Researchers in the Soskic Group at Human Techno...
16/04/2026

🧬 How do B cells choose between fast defence and long-term protection?

🔬 Researchers in the Soskic Group at Human Technopole have mapped the molecular programmes that guide naive and memory B cells after activation. Published in Molecular Systems Biology, the study shows how these cells follow distinct paths that shape antibody responses.

💡 By revealing the molecular switches behind these fate decisions, this work could inform future research on vaccination, infection and autoimmune disease, advancing science for human health.

Read more 👉

Human Technopole researchers have identified the molecular programmes that drive human B cell differentiation after activation, shedding new light on how the immune system balances rapid defence with long-term protection. The findings are published in Molecular Systems Biology.

[CANCELED] 🧬 How do cells package and control their messages? 🎙️ Join us for the next “HT Seminars: Connecting Discoveri...
14/04/2026

[CANCELED] 🧬 How do cells package and control their messages?

🎙️ Join us for the next “HT Seminars: Connecting Discoveries” talk on 14 May with Elena Conti of the Max Planck Institute of Biochemistry.

🔬 A leading structural biologist, she studies how cells monitor, transport and degrade mRNA, revealing the molecular mechanisms that recognise and remove defective or unneeded transcripts. Her work shows how fundamental discoveries across scales can deepen our understanding of human biology and help shape the future of human health.

Register 👉 https://humantechnopole.it/en/training/external-training/external-seminar-series-2026/ #14-may-2026-elena-conti

🌍 The event is part of 2026, the annual festival transforming MIND Milano Innovation District into a hub for dialogue, experimentation and ideas. This year’s theme, “The origin of ideas”, puts people, curiosity and collaboration at the centre of innovation.

🚀 HSIL Hackathon 2026 was a great success at MIND Milano Innovation District, with more than 320 applications received a...
13/04/2026

🚀 HSIL Hackathon 2026 was a great success at MIND Milano Innovation District, with more than 320 applications received and 100+ selected participants joining in 20+ teams to develop AI-driven solutions for high-value health systems.

🤝 We were proud to contribute through our Michela Carlotta Massi, Health Data Science, and our Soumick Chatterjee, Genomics Research Centre, as mentors, and our Florian Jug, Head of Computational Biology Research Centre – Multimodal AI Across Scales, as one of the judges.

🏆 Congratulations to our Camilla Callierotti, Bioinformatician at the National Facility for Data Handling and Analysis, whose team placed 3rd overall with Previo. A strong result that reflects the value of interdisciplinary teamwork and shared ambition in shaping the future of human health together.

📍 Thank you to all mentors and judges who helped make this collaborative experience possible. With Università degli Studi di Milano, Politecnico di Milano, Federated Innovation , SIIAM, Fondazione Triulza. Organized by Harvard T.H. Chan School of Public Health's Harvard Health Systems Innovation Lab.

🧬 How does 3D biology change the way we understand life, from genome to proteins? 🔬 On 19 April, our Piero Carninci, Hea...
10/04/2026

🧬 How does 3D biology change the way we understand life, from genome to proteins?

🔬 On 19 April, our Piero Carninci, Head of the Genomics Research Centre – Functional Genomics Programme, will speak at the Festival delle Scienze di Roma in a conversation on how genomics, proteomics, advanced sequencing and AI are helping us decode the three-dimensional complexity of biological systems and opening new paths towards more personalised medicine.

🤝 Joining him will be Dafne Campigli Di Gianmartino, ISTITUTO ITALIANO DI TECNOLOGIA, winner of the first call of HT’s Early Career Fellowship Programme in 2021; Alberto Cazzaniga, Area Science Park; and Andrea Bettini, Rai News 24, moderating.

👉 https://www.auditorium.com/it/event/la-complessita-tridimensionale-dal-genoma-alle-proteine/ Festival delle Scienze Roma

🧬 How do genetic variants drive immune-mediated disease?🎙️ Join the next “HT Seminars: Connecting Discoveries” talk on 3...
09/04/2026

🧬 How do genetic variants drive immune-mediated disease?

🎙️ Join the next “HT Seminars: Connecting Discoveries” talk on 30 April with Soumya Raychaudhuri of Harvard Medical School, Brigham and Women’s Hospital and the Broad Institute.

🔬 His research brings together computational biology, human immunology and genetic engineering to understand how disease-associated alleles shape cell states and inflammation.

Register here 👉 https://humantechnopole.it/en/training/external-training/external-seminar-series-2026/ #30-april-2026-soumya-raychaudhuri

07/04/2026

🌍 On , this year’s theme “Together for health. Stand with science” reminds us that advancing human health is a shared responsibility.

🧬 Our Director Marino Zerial reflects on what it means to shape the future of human health together: connecting fundamental research with clinical insight, data science and technology.

🔬 At Human Technopole, collaboration is how we work every day: bringing together diverse expertise, shared infrastructures and open science to understand disease and translate discoveries into impact, improving human life.

Indirizzo

Palazzo Italia, Viale Rita Levi-Montalcini 1
Milan
20157

Notifiche

Lasciando la tua email puoi essere il primo a sapere quando Human Technopole pubblica notizie e promozioni. Il tuo indirizzo email non verrà utilizzato per nessun altro scopo e potrai annullare l'iscrizione in qualsiasi momento.

Contatta Lo Studio

Invia un messaggio a Human Technopole:

Condividi

L’istituto italiano per le scienze della vita

Human Technopole è l’istituto italiano di ricerca per le Scienze della Vita e ha sede a Palazzo Italia, di fronte all’Albero della vita, all’interno di MIND – Milan Innovation District.

Vogliamo promuovere la salute e il benessere delle persone attraverso lo sviluppo di approcci personalizzati per la cura di numerose malattie.

In Human Technopole lavoreranno 1.000 scienziati – selezionati secondo procedure trasparenti ed internazionali – che potranno contare su un campus di 55.000 m2 di cui 35.000m2 dedicati a laboratori interdisciplinari.

I principi di trasparenza, apertura e collaborazione guidano il rapporto con i partner esterni: le infrastrutture di ricerca saranno aperte alla comunità scientifica su base competitiva e meritocratica.